Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$0.6 - $1.65 $51,111 - $140,555
-85,185 Reduced 33.74%
167,314 $123,000
Q3 2023

Nov 09, 2023

SELL
$1.67 - $3.33 $251,403 - $501,301
-150,541 Reduced 37.35%
252,499 $424,000
Q2 2023

Aug 09, 2023

SELL
$2.83 - $4.94 $1.54 Million - $2.68 Million
-542,842 Reduced 57.39%
403,040 $1.14 Million
Q1 2023

May 12, 2023

SELL
$4.89 - $12.27 $346,593 - $869,673
-70,878 Reduced 6.97%
945,882 $4.64 Million
Q4 2022

Feb 09, 2023

BUY
$8.88 - $12.77 $19,518 - $28,068
2,198 Added 0.22%
1,016,760 $10.9 Million
Q3 2022

Nov 10, 2022

SELL
$8.24 - $12.56 $243,401 - $371,009
-29,539 Reduced 2.83%
1,014,562 $9.5 Million
Q2 2022

Aug 12, 2022

BUY
$7.45 - $13.84 $1.88 Million - $3.49 Million
251,910 Added 31.8%
1,044,101 $9.53 Million
Q1 2022

May 13, 2022

BUY
$9.94 - $12.65 $2.59 Million - $3.3 Million
260,841 Added 49.09%
792,191 $9.63 Million
Q4 2021

Feb 09, 2022

BUY
$11.99 - $18.14 $2.13 Million - $3.22 Million
177,265 Added 50.06%
531,350 $6.47 Million
Q3 2021

Nov 12, 2021

SELL
$11.55 - $16.06 $769,068 - $1.07 Million
-66,586 Reduced 15.83%
354,085 $5.47 Million
Q2 2021

Aug 12, 2021

BUY
$12.38 - $29.19 $4.42 Million - $10.4 Million
357,302 Added 563.84%
420,671 $6 Million
Q1 2021

May 14, 2021

SELL
$15.07 - $21.71 $81,136 - $116,886
-5,384 Reduced 7.83%
63,369 $1.37 Million
Q4 2020

Feb 25, 2021

BUY
$12.72 - $16.16 $874,538 - $1.11 Million
68,753 New
68,753 $1.04 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.